diversity

Case Study: Phase III clinical trial in the United States | 2022

Client A biopharmaceutical company sponsoring a Phase III clinical trial in the United States. Challenge The trial required recruitment of patients with a neurological pain indication.  The sponsor perceived a potential concern that patients had several alternative treatment options, including commercially available products, and therefore, may not be interested in a clinical study opportunity for…